Publication | Closed Access
The Value of Combination Analysis of Tumor Biomarkers for Early Differentiating Diagnosis of Lung Cancer and Pulmonary Tuberculosis.
18
Citations
0
References
2019
Year
The combination of CEA, CYFRA21-1, and NSE possesses better values for identifying lung cancer patients who are at a high risk of being misdiagnosed for pulmonary tuberculosis.